Abstract
Interactions between oligodeoxyribonucleotides (ODN) with different sequences and cell proteins were examined using the affinity modification by [32P]-labeled reactive oligonucleotide derivatives. 3"-Terminal ribouridine oxidized with sodium periodate, 4-[(N-2-chloroethyl-N-methyl)amino]benzylamine, and the maleimide residue were used as reactive groups. All the compounds used are specific reagents. The set of the discovered nucleic acid-binding (NA-binding) proteins depends on the chemical properties of the affinity reagent. The presence of the hydrophobic group at the 5"-terminus of the ODN molecule is the key factor determining the variety of the discovered NA-binding proteins. The cells of different origin (A431, HeLa, KB, MCF-7, Hap-2, K562, Cos-7, NIH/3T3, human-lung primary epithelial cells, and porcine kidney primary cells) are characterized by the same set of NA-binding proteins whose affinity modifications depends on the conditions of incubation of oligonucleotides with the cells. Treatments of cells disturbing the integrity of the cellular membrane (scrapping, treatment with trypsin, or cell permeabilization with streptolysin O or saponin), disrupt interactions between NA-binding proteins from native cells and ODN.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
D. G. Knorre, V. V. Vlassov, and V. F. Zarytova, in Oligodeoxynucleotides, Ed. J. S. Cohen, CRC Press Inc., Boca Raton, 1989, 173.
V. V. Vlassov, I. E. Vlassova, and L. V. Pautova, Prog. Nucleic. Acid. Res. Mol. Biol., 1997, 57, 95.
E. Yu. Rykova, P. P. Laktionov, and V. V. Vlassov, Nucleosides Nucleotides, 1997, 16, 1883.
E. Yu. Rykova, P. P. Laktionov, and V. V. Vlassov, Vaccine, 1999, 17, 1193.
S. Wu-Pong, T. L. Weiss, and C. A. Hunt, Antisense Res. Dev., 1994, 4, 155.
S. Wu-Pong, T. L. Weiss, and C. A. Hunt, Cell. Mol. Biol., 1994, 40, 843.
S. L. Loke, C. A. Stein, X. Zhang, K. Mori, M. Nakanishi, C. Subasinghe, J. S. Cohen, and L. M. Neckers, Proc. Natl. Acad. Sci. USA, 1989, 86, 6474.
R. M. Bennett, Antisense Res. Dev., 1993, 3, 235.
B. Hanss, E. Leal-Pinto, L. A. Bruggeman, T. D. Copeland, and P. E. Klotman, Proc. Natl. Acad. Sci. USA, 1998, 95, 1921.
A. D. Gezelowitz and L. M. Neckers, Antisense Res. Dev., 1992, 2, 17.
P. Diesbach, C. Derens, F. N'Kull, M. Monsigny, E. Sonveaux, R. Wattiez, and P. J. Courtoy, Nucleic Acids Res., 2000, 28, 868.
G. Q. Yao, S. Corrias, and Y. C. Cheng, Biochem. Pharmacol., 1996, 51, 431.
P. P. Laktionov, J.-E. Dazard, E. Vives, E. Yu. Rykova, J. Piette, V. V. Vlassov, and B. Lebleu, Nucleic Acids Res., 1999, 27, 2315.
P. P. Laktionov, B. Chelobanov, E. Rykova, and V. Vlassov, Nucleosides Nucleotides Nucleic Acids, 2001, 20, 859.
L. A. Yakubov, E. A. Deeva, V. F. Zarytova, E. M. Ivanova, A. S. Ryte, L. V. Yurchenko, and V. V. Vlassov, Proc. Natl. Acad. Sci. USA, 1989, 86, 6454.
C. Beltinger, H. U. Saragovi, R. M. Smith, L. LeSauteur, N. Shah, L. DeDionisio, L. Christensen, A. Raible, L. Jarett, and A. M. Gewirtz, J. Clin. Invest., 1995, 4, 1814.
L. Benimetscaya, J. D. Loike, Z. Khakled, G. Loike, S. C. Silverstein, L. Cao, R. Y. Elkhoury, J. Cai, and C. A. Stein, Nature Med., 1997, 2, 414.
Y. Kimura, K. Sonehara, E. Kuramoto, T. Makino, S. Yamamoto, T. Yamamoto, T. Kataoka, and T. Tokunaga, J. Biochem., 1994, 116, 991.
M. Duran, K. Chevrie, M. Chassignol, N. T. Thuong, and J. C. Maurizot, Nucleic Acids Res., 1990, 18, 6353.
G. F. Mishenina, V. V. Samukov, and T. N. Shubina, Bioorg. Khim. 1979, 5, 886 [Sov. J. Bioorg. Chem., 1979, 5, 886 (Engl. Transl.)].
V. V. Vlasov, E. Yu. Rykova, L. V. Pautova, and L. A. Yakubov, Biokhimiya, 1993, 58, 1247 [Biochemistry (Moscow), 1993, 58, 1247 (Engl. Transl.)].
J. Haralambidis, M. Chai, and G. W. Tregear, Nucleic Acids Res., 1987, 15, 4857.
M. J. O´Sullivan, E. Gnemmi, D. Morris, G. Chieregatti, M. Simmons, A. D. Simmonds, J. W. Bridges, and V. Marks, FEBS Lett., 1978, 98, 311.
M. R. Gold, R. Chiu, R. J. Ingham, T. M. Saxton, I. V. Oostveen, J. D. Watts, M. Affolter, and R. Aebersold, J. Immunol., 1994, 153, 2369.
E. Rykova, L. V. Pautova, L. A. Yakubov, V. N. Karamyshev, and V. V. Vlassov, FEBS Lett., 1994, 344, 96.
O. Ullrich, H. Horiuchi, K. Alexandrov, and M. Zerial, Methods Enzymol., 1995, 257, 243.
C. Griffoni, P. P. Laktionov, E. Y. Rykova, E. Spisni, M. Riccio, S. Santi, A. Bryksin, N. Volodko, R. Kraft, V. Vlassov, and V. Tomasi, Biochim. Biophys. Acta: Mol. Cell. Biol. Lipids, 2001, 1530, 32.
P. Hawley and I. Gibson, Antisense Nucleic Acid Drug Development, 1996, 6, 185.
C. A. Stein, A. M. Cleary, L. Yakubov, and S. Lederman, Antisense Res. Dev., 1993, 3, 19.
L. Yakubov, Z. Khaled, L. M. Zhang, A. Truneh, V. Vlassov, and C. A. Stein, J. Biol. Chem., 1993, 268, 18818.
P. Hawley, J. S. Nelson, K. L. Fearon, G. Zon, and I. Gibson, Antisense Nucleic Acid Drug Development, 1999, 9, 61.
P. P. Laktionov, E. Yu. Rykova, and V. V. Vlassov, Mol. Biologiya, 1997, 31, 506 [Russ. Mol. Biol., 1997, 31, 506 (Engl. Transl.)].
S. B. Noonberg, M. R. Garovoy, and C. A. Hunt, Investigative Dermatology, 1993, 101, 727.
G. Hartman, M. Bidlingmaier, B. Jahrsdorfer, A. Krug, U. Hacker, A. Eigler, and S. Endres, Nucleosides Nucleotides, 1998, 17, 1767.
P. L. McNeil and R. A. Steinhardt, J. Cell. Biol., 1997, 137, 1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chelobanov, B.P., Laktionov, P.P., Khar"kova, M.V. et al. Investigation of surface oligonucleotide-binding proteins of eucaryotic cells by affinity modification with reactive oligonucleotide derivatives. Russian Chemical Bulletin 51, 1204–1211 (2002). https://doi.org/10.1023/A:1020992227792
Issue Date:
DOI: https://doi.org/10.1023/A:1020992227792